Elucidation on type Ⅰ interferonopathies
10.3760/cma.j.cn101070-20201204-01852
- VernacularTitle:认识I型干扰素病
- Author:
Zhongxun YU
1
;
Hongmei SONG
Author Information
1. 中国医学科学院北京协和医院儿科，北京 100730
- Keywords:
Autoinflammatory disease;
Type Ⅰ interferonopathy;
JAK inhibitor
- From:
Chinese Journal of Applied Clinical Pediatrics
2022;37(1):2-5
- CountryChina
- Language:Chinese
-
Abstract:
Type Ⅰ interferonopathies is a relatively new group of diseases in the last decade, which belong to auto-inflammatory disorders characterized by robust inflammation.Its low incidence and diverse clinical manifestations make it difficult for the clinical identification and diagnosis of this disease.In this article, the concept, pathogenesis, diagnosis and treatment options of this disease was introduced briefly, in order to enhance clinicians′ knowledge of them, thus achieving the goal of early recognition, early detection, early identification and early intervention for the benefit of more patients and their families.
